OXFORD BIOMEDICA
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and manufacture. Gene therapy is the treatment of disease by delivering therapeutic DNA into a patient’s cells. This can be either in vivo or ex vivo, the latter encompassing the field of cell therapy whereby genetically modified cells are put back into the body. Their pipeline of seven gene and cell therapy therapy products addresses diseases for... which there is currently no treatment or that are inadequately treated today, including ocular and central nervous system disorders. Their product candidates have the potential to transform treatment landscapes. Their strategy is to develop their product candidates to their next value inflection points whilst continuing to build OXB Solutions into a valuable revenue-generating manufacturing and development services business.
OXFORD BIOMEDICA
Industry:
Biotechnology Genetics Therapeutics
Founded:
1995-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxb.com
Total Employee:
51+
Status:
Active
Contact:
+4401865783000
Email Addresses:
[email protected]
Total Funding:
62.3 M GBP
Technology used in webpage:
SPF Domain Not Resolving Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Mimecast
Similar Organizations
4BIO Capital
4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amsterdam Scientific Instruments
Amsterdam Scientific Instruments specializes in the fields of neutron detection, electron imaging, and X-ray detector technology.
Arctos Medical
Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
arGEN-X
arGEN-X offers a platform for antibody lead choice that supports the discovery of human antibody therapeutics.
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
BioCryst Pharmaceuticals
BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.
Celyad
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
Chameleon Biosciences
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
DNAdigest
DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.
EG 427
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
Enara Bio
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Evaxion Biotech
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Genetic Analysis
Genetic Analysis has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Coave Therapeutics
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Horizon Discovery
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Hybrigenics
Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
Intima Biosciences
Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures.
Nouscom
Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Reithera Srl
Reithera Srl is a company devoted to develop and produce biopharmaceutical products based on gene delivery technologies
Riboxx
Riboxx LIFE SCIENCES develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference:
RoslinCT
RoslinCT is a UK Cell Therapy Contract Development and Manufacturing Organisation.
Sino-Biocan
Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.
T-knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Xenothera
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-03-12 | Oxxon Therapeutics | Oxxon Therapeutics acquired by Oxford BioMedica | 16 M GBP |
Investors List
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Post-IPO Equity - Oxford BioMedica
Innovate UK
Innovate UK investment in Grant - Oxford BioMedica
Official Site Inspections
http://www.oxb.com Semrush global rank: 496.53 K Semrush visits lastest month: 100.57 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Oxford BioMedica"
Our ESG mission and responsible business strategy
OXB’s four values, “Responsible, Responsive, Resilient and Respect”, govern the way that OXB does business, how OXB works together, and the interactions OXB has with all its stakeholders. OXB’s values and the associated behaviours are …See details»
Oxford Biomedica - Wikipedia
The company was established in 1995 as a spin out from the University of Oxford. It was the subject of an initial public offering on the Alternative Investment Market in 1996. In 2018, OXBs gene therapy for Parkinson's disease became the subject of a commercialization deal with Axovant Sciences. In May 2019, the company announced an investment by Novo Holdings for a stake of 10.1% in …See details»
Full Year Trading Update and Notice of Preliminary Results - OXB
Feb 17, 2025 Frank Mathias, Chief Executive Officer of OXB, commented: “We are continuing to execute our multi-vector, multi-site “One OXB” strategy, and have successfully Oxford, UK – …See details»
Oxford Biomedica forms expert advisory board to drive innovation
1 day ago LONDON - Oxford Biomedica PLC (LSE:OXB), a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the …See details»
OXB Launches Advisory Board - London Stock Exchange
2 days ago OXB Launches Advisory Board - London Stock Exchange ... nullSee details»
About OXB | PharmiWeb.jobs
Mar 12, 2025 OXB is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its …See details»
Oxford Biomedica plc (LON: OXB) Company Profile & Overview
Nov 6, 2024 Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a …See details»
Oxford Biomedica - PharmaSource
Oxford Biomedica (OXB) is a pioneering contract development and manufacturing organisation (CDMO) specialising in viral vector production for cell and gene therapies. With over 25 years …See details»
Oxford Biomedica Rebrands to OXB with OXB.com - Smart Branding
In contrast, OXB presents a more flexible and universal brand. Alongside the rebrand, the company acquired the domain OXB.com. Three-letter .com domains are highly prized for their …See details»
OXB, OXB:LSE profile - FT.com - Financial Times
5 days ago Oxford Biomedica PLC is a contract development and manufacturing organization (CDMO) in cell and gene therapy. It provides viral vector development and manufacturing …See details»
Our Missions and Values - careers.oxb.com
Our Mission. Our mission is delivering life-changing gene therapies to patients. Our product candidates span oncology, ophthalmology, liver diseases, respiratory disease and CNS …See details»
OXB Highlights the Launch of its Innovation and Technology …
1 day ago Dr. Frank Mathias, Chief Executive Officer of OXB, commented: “The Innovation and Technology Excellence Board marks a key step in OXB’s evolution as a pure-play CDMO …See details»
Oxford BioMedica - Crunchbase Company Profile & Funding
Organization. Oxford BioMedica . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Oxford BioMedica is a pioneer of …See details»
Oxford Biomedica Overview | SignalHire Company Profile
Oxford Biomedica (LSE: OXB) is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of ...See details»
Investor Information - OXB
Financial calendar Upcoming events Date 2022 Interim Results Announcement Q3 2022 Analyst coverage The following analysts cover Oxford Biomedica: Company Analyst Telephone …See details»
Oxford BioMedica - Overview, News & Similar companies
Jul 16, 2024 Oxford Biomedica (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life changing treatments for serious d iseases. Oxford Biomedica …See details»
Oxford Biomedica Company Overview, Contact Details
Dec 5, 2023 Oxford Biomedica. Pharmaceutical Manufacturing Oxfordshire, United Kingdom 501-1000 Employees. OXB (LSE: OXB) is a global quality and innovation-led contract …See details»
Rewards and Benefits - careers.oxb.com
You own your development at OXB and we support you to get to where you want to be, wherever that might be. Our blended approach provides our employees opportunities for continuous …See details»
OXB - Organizations - Acronym Finder
What does OXB stand for? Your abbreviation search returned 2 meanings. showing only Organizations definitions . Link/Page Citation Category Filters; All definitions (2) Information …See details»
Services - OXB - Oxford Biomedica USA
We can reliably take you from laboratory concept through to clinical-grade manufacturing and large scale commercial production. Thanks to systems and processes that have been carefully …See details»